Borkowski Astrid 4
4 · HilleVax, Inc. · Filed Feb 3, 2023
Insider Transaction Report
Form 4
HilleVax, Inc.HLVX
Borkowski Astrid
Chief Medical Officer
Transactions
- Award
Common Stock
2023-02-01+51,333→ 219,774 total - Award
Stock Option (Right to Buy)
2023-02-01+77,000→ 77,000 totalExercise: $18.00Exp: 2033-01-31→ Common Stock (77,000 underlying)
Footnotes (3)
- [F1]Represents restricted stock units ("RSUs") which will vest as to 25% of the total number of RSUs granted on each of the first four anniversaries of February 1, 2023, subject to the reporting person's continuous service to the Issuer on the applicable vesting dates. Each RSU represents a contingent right to receive one share of common stock of the Issuer and the RSUs have no expiration date.
- [F2]Includes 341 shares acquired under the HilleVax, Inc. employee stock purchase plan on November 15, 2022.
- [F3]The option is exercisable as it vests. The option will vest with respect to 25% of the shares of common stock on February 1, 2024, and will vest with respect to the remaining shares in equal monthly installments over the following three years subject to the reporting person's continuous service to the Issuer on the applicable vesting dates.